Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 7
2021 5
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Glucose-lowering drugs, cognition, and dementia: The clinical evidence.
Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, Swardfager W. Wu CY, et al. Among authors: ouk m. Neurosci Biobehav Rev. 2022 Jun;137:104654. doi: 10.1016/j.neubiorev.2022.104654. Epub 2022 Apr 6. Neurosci Biobehav Rev. 2022. PMID: 35398114 Review.
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseases.
Zebarth J, Kamal R, Perlman G, Ouk M, Xiong LY, Yu D, Lin WZ, Ramirez J, Masellis M, Goubran M, MacIntosh BJ, Black SE, Cogo-Moreira H, Scott CJM, Bartha R, Symons S, Haddad SMH, Ozzoude M, Nanayakkara N, Beaton D, Arnott S, Dowlatshahi D, Swartz RH, Saposnik G, Grimes D, Lang A, Fischer CE, Frank A, Kumar S, Pollock BG, Tang-Wai D, Finger E, Rabin JS, Swardfager W. Zebarth J, et al. Among authors: ouk m. J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107273. doi: 10.1016/j.jstrokecerebrovasdis.2023.107273. Epub 2023 Aug 3. J Stroke Cerebrovasc Dis. 2023. PMID: 37542762
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.
Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, Haydarian E, Li S, Fang Y, Li P, Pakosh M, Tartaglia MC, Masellis M, Swardfager W. Wong YY, et al. Among authors: ouk m. Parkinsonism Relat Disord. 2022 Aug;101:119-128. doi: 10.1016/j.parkreldis.2022.06.004. Epub 2022 Jun 20. Parkinsonism Relat Disord. 2022. PMID: 35760718 Review.
Academic Promotions in Medicine: An Appraisal of Fairness.
Warsame R, Kim YH, Ouk MY, Mara KC, Lacy MQ, Hayes SN, Shalle Z, Balls-Berry J, Jordan BL, Enders FT, Wolanskyj-Spinner AP, Spinner RJ. Warsame R, et al. Among authors: ouk my. Mayo Clin Proc. 2024 Mar;99(3):424-434. doi: 10.1016/j.mayocp.2023.05.013. Mayo Clin Proc. 2024. PMID: 38432747
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
Ouk M, Wu CY, Rabin JS, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W; Alzheimer’s Disease Neuroimaging Initiative. Ouk M, et al. Neurobiol Aging. 2021 Apr;100:22-31. doi: 10.1016/j.neurobiolaging.2020.12.011. Epub 2020 Dec 16. Neurobiol Aging. 2021. PMID: 33461049
18 results